化工社化工社 化学情報印刷レポート · 研究参考用
N,N'-(1,2-シクロヘキサンジイル)ビス[N-(カルボキシメチル)グリシン]
1,2-ビス[ビス(2-オキソ-2-ヒドロキシエチル)アミノ]シクロヘキサン · 1,2-シクロヘキサンジイルビスニトリロ四酢酸 · 1,2-ジアミノシクロヘキサンN,N,N',N'-四酢酸 · (シクロヘキサン-1,2-ジイルビスニトリロ)四酢酸 · シクロヘキサン-1,2-ジイルビス(ニトリロ)四酢酸 · [(シクロヘキサン-1,2-ジイル)ビスニトリロ]四酢酸 · 2,2',2'',2'''-(1,2-シクロヘキサンジイルビスニトリロ)テトラキス酢酸 · 3,3'-(シクロヘキサン-1,2-ジイル)ビス(3-アザペンタン二酸)
![N,N'-(1,2-シクロヘキサンジイル)ビス[N-(カルボキシメチル)グリシン] の分子構造式](/img/chemical/10213.png)
識別子と物理属性
| CAS No. | 482-54-2 |
|---|---|
| 分子式 | C14H22N2O8 |
| 平均分子量 | 346.33 g/mol |
| 単同位体質量 | 346.13761566 g/mol |
| SMILES | O=C(O)CN(CC(=O)O)C1CCCCC1N(CC(=O)O)CC(=O)O |
| InChIKey | FCKYPQBAHLOOJQ-UHFFFAOYSA-N |
| PubChem CID | 10213 |
| ChEBI | CHEBI:188859 |
| EC No. | 207-582-7 |
| DTXSID | DTXSID80862002 |
| 現地名 | N,N'-(1,2-シクロヘキサンジイル)ビス[N-(カルボキシメチル)グリシン] |
化学・物理的性質
| XLogP | -4.5 |
|---|---|
| 極性表面積 | 156 |
| 水素結合供与体数 | 4 |
| 水素結合受容体数 | 10 |
| 回転可能結合数 | 10 |
| 重原子数 | 24 |
| 形式電荷 | 0 |
| 複雑度 | 419 |
| 物質分類 | Nitrogen Compounds -> Amino Carboxylic Acids |
| 化粧品 | Chelating |
| Physical Description | Tan solid[Acros Organics MSDS] |
| 融点 | 215 °C |
| 沸点 | 481.08°C (rough estimate) |
| 密度 | 1.2530 (rough estimate) |
| 屈折率 | 1.5110 (estimate) |
| 貯蔵条件 | Sealed in dry,Room Temperature |
| pKa(酸解離定数) | 1.78±0.10(Predicted) |
| 化粧品成分の機能 | キレート化 |
| InChI | InChI=1S/C14H22N2O8/c17-11(18)5-15(6-12(19)20)9-3-1-2-4-10(9)16(7-13(21)22)8-14(23)24/h9-10H,1-8H2,(H,17,18)(H,19,20)(H,21,22)(H,23,24) |
| InChIKey | FCKYPQBAHLOOJQ-UHFFFAOYSA-N |
| SMILES | C1(N(CC(O)=O)CC(O)=O)CCCCC1N(CC(O)=O)CC(O)=O |
| LogP(分配係数) | 0.070 (est) |
| EPAの化学物質情報 | Glycine, N,N'-1,2-cyclohexanediylbis[N-(carboxymethyl)- (482-54-2) |
安全性と法規制
| GHS 分類 | This chemical does not meet GHS hazard criteria for 96.9% (63 of 65) of all reports.Not ClassifiedAggregated GHS information provided per 65 reports by companies from 3 notifications to the ECHA C&L Inventory. |
|---|---|
| 規制情報 | Chemical: Glycine, N,N'-1,2-cyclohexanediylbis[N-(carboxymethyl)-Glycine, N,N'-1,2-cyclohexanediylbis[N-(carboxymethyl)-: Does not have an individual approval but may be used under an appropriate group standard |
| 有害性の概要 | Causes convulsions, aggression, and chronic pulmonary edema in intraperitoneal lethal-dose studies of rats (LD50 = 413 mg/kg)[RTECS] May cause mild irritation[Acros Organics MSDS] See Edetic acid. See 1,3-Cyclohexanediamine. |
| Hazard Classes and Categories | Not Classified |
| Treatment | The antibiotics metronidazole and vancomycin have been shown to be effective against Clostridium difficile. (L1730) |
| 健康影響 | Toxins A is an enterotoxin from Clostridium difficile and causes antibiotic-associated diarrhea and pseudomembranous colitis. (A341 , A340, L1730) |
| 暴露経路 | Ingestion (L1816)inhalation (L1816)dermal (L1816) |
| 毒性の概要 | Rho GTPases are activated by glucosylation (for example RhoA at Thr37). The toxins catalyze the transfer of a glucosyl moiety from UDP-glucose to the Rho GTPases. The covalent attachment of the glucose moiety to a conserved threonine within the effector region of the GTPases renders the Rho-GTPases functionally inactive. As a consequence, the actin cytoskeleton is disaggregated and this is accompanied by cell rounding and formation of an arborized morphology. (A341, A340) |
| Signs and Symptoms | Symptoms of Clostridium difficile infection include bloating, constipation, and diarrhea with abdominal pain, which may become severe. Latent symptoms often mimic some flu-like symptoms. (L1730) |
| Carcinogen Classification | No indication of carcinogenicity to humans (not listed by IARC). |
| Toxicity Data | LD50: 500 ng/kg (Intraperitoneal, Mouse) (A2855) |
用途
使用
1,2-Cyclohexylenedinitrilotetraacetic Acid is used as a chelating agent in the phytoextraction of Ni from contaminated soil.